Air Cargo Delays Put Patient Treatment at Risk

What if air freight capacity to your primary markets drops by 20% unexpectedly?

Model a scenario where available air cargo capacity to key pharmaceutical distribution hubs decreases by 20% due to flight cancellations, carrier consolidations, or geopolitical disruptions. Assume your organization currently fulfills 60% of critical pharmaceutical orders via air freight with 2-3 day transit times. Simulate the impact on order fulfillment rates, required safety stock increases, and whether alternative transportation modes (ocean freight with expedited inland routing, ground express) can absorb displaced volume without exceeding cost thresholds or violating delivery SLAs.

What if cold-chain air cargo delays increase by 5 days on average?

Model extended delays in temperature-controlled air freight (5-day increase in average transit time) due to congestion at cold-chain handling facilities or carrier scheduling constraints. For temperature-sensitive pharmaceutical products with 14-21 day shelf lives post-shipment, simulate the impact on product expiration rates, treatment schedule delays, and the financial impact of spoilage. Calculate required inventory buffer increases and optimal safety stock levels to maintain service levels under this delay scenario.

What if you diversify 30% of air freight volume to alternative carriers?

Model shifting 30% of your air freight volume from primary carriers to secondary or regional carriers with slightly longer transit times (1-2 days longer) but potentially better availability during capacity crunch periods. Simulate the cost impact of diversification (including potential rate premiums), service level changes, and operational complexity (managing multiple carrier relationships, systems integration). Calculate the break-even point where reliability gains offset higher logistics costs and increased operational overhead.